spacer
home > events calendar
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR
   
  {prev}
EVENTS FOR 2017
{next}  
   
 
EVENTS FOR ALL MAGAZINES
 
     

RDD Europe 2017

25-28 April 2017
Palais des Congres díAntibes, Nice (Antibes), France

RDD Europe 2017, organized by RDD Online and Aptar Pharma will be held in Nice (Antibes), France, April 25-28, 2017. More>>

 
 

LogiPharma Europe

25-27 April 2017
Montreux Music & Convention Centre, Switzerland

Now in its 17th successful year, LogiPharma is the largest global end-to-end supply chain event for pharma supply chain leaders, their teams and service partners. More>>

 
phone 44 (0) 20 7368 9854
email logipharma@wbr.co.uk
web bit.ly/2mhwYgC
email Montreux Music & Convention Centre, Switzerland
 

BioProcess International European Summit

25-26 April 2017
RAI, Amsterdam

BioProcess International European Summit is THE Bioprocessing event, bringing together 800+ attendees from all major departments in bioprocessing: Cell Culture, Downstream, Manufacturing, Vaccines, Viral Safety and Cell Line Development. Find out more: https://goo.gl/d64sXs More>>

 
 

World Orphan Drug Congress USA 2017

19-21 April 2017
Washington Mariott Wardman Park, Washington, DC.

THE GLOBAL ORPHAN DRUG CONFERENCE AND EXPO IS BACKOver its 7-year history, the shape of the World Orphan Drug Congress USA has changed from a small conference focused on the US market, to a 4 track event, with over 1,000 global attendees, coming together to discuss the latest trends. More>>

 
phone +1 646 619 1811
email freya.smale@terrapinn.com
web https://goo.gl/1XG74o
email Washington Mariott Wardman Park, Washington, DC.
 

9th Adaptive Designs in Clinical Trials

3-4 April 2017
Copthorne Tara Hotel, London, UK

SMiís annual conference on Adaptive Designs in Clinical Trials will return to London on 3rd & 4th April 2017. Now running for nearly a decade, this unmissable event will gather a senior audience of experts to discuss and deliberate recent innovations and successes in this exciting field of science. More>>

 
phone +44 207 827 6000
email events@smi-online.co.uk
web bit.ly/2mTgPPv
email Copthorne Tara Hotel, Scarsdale Place, Kensington, London
 
spacer
Industry Events

Outsourcing in Clinical Trials Southeast 2018

13-14 March 2018, Durham, North Carolina

This yearís Outsourcing in Clinical Trials event builds on last yearís incredibly successful conference which will once again be returning to North Carolina with the aim of supporting trial sponsors and solution providers in the RTP and neighboring regions, ensuring trials are delivered on time and partnerships are bettered.
More info >>

Banner of Clinical_Trial_New_England_events_95 on Samedan

Banner of ChinaBio_Events_102 on Samedan
White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

RSSL

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>


News and Press Releases

Denny Bros Group continues its support of Packaging Innovations

A world leading print company is preparing to showcase its renowned labelling and printing solutions at next monthís prestigious Packaging Innovations show.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement